Nuo Therapeutics, Inc. (AURX): Total Liabilities

Annual figures by period end, from SEC filings.

$2.80M
As of 2025-12-31
$4.16M
As of 2026-06-30
+48.5%
3-year compound annual growth
+33.3%
5-year compound annual growth
-23.9%
10-year compound annual growth
$43.13M2010-12-31: $8.98M2011-12-31: $6.80M2012-12-31: $6.33M2013-12-31: $19.44M2014-12-31: $40.26M2015-12-31: $43.13M2016-12-31: $1.57M2017-12-31: $941.2K2018-12-31: $1.06M2019-12-31: $1.49M2020-03-31: $1.01M2020-06-30: $1.02M2020-09-30: $1.03M2020-12-31: $665.0K2021-03-31: $666.5K2021-06-30: $668.9K2021-09-30: $672.5K2021-12-31: $673.1K2022-12-31: $856.0K2023-12-31: $838.7K2024-12-31: $675.8K2025-12-31: $2.80M$2.80M
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$2.80M+314.7%2026-03-30, Balance as of period end
2024-12-31$675.8K-19.4%2026-03-30, Balance as of period end
2023-12-31$838.7K-2.0%2025-04-01, Balance as of period end
2022-12-31$856.0K+27.2%2024-04-19, Balance as of period end
2021-12-31$673.1Kn/a2023-04-17, Balance as of period end
2021-09-30$672.5Kn/a2022-04-15, Balance as of period end
2021-06-30$668.9Kn/a2022-04-15, Balance as of period end
2021-03-31$666.5Kn/a2022-04-15, Balance as of period end
2020-12-31$665.0Kn/a2022-04-15, Balance as of period end
2020-09-30$1.03Mn/a2022-04-15, Balance as of period end
2020-06-30$1.02Mn/a2022-04-15, Balance as of period end
2020-03-31$1.01Mn/a2022-04-15, Balance as of period end
2019-12-31$1.49M+40.5%2022-04-15, Balance as of period end
2018-12-31$1.06M+12.4%2019-04-16, Balance as of period end
2017-12-31$941.2K-40.1%2019-04-16, Balance as of period end
2016-12-31$1.57M-96.4%2018-04-16, Balance as of period end
2015-12-31$43.13M+7.1%2016-10-24, Balance as of period end
2014-12-31$40.26M+107.1%2016-10-24, Balance as of period end
2013-12-31$19.44M+207.2%2015-03-31, Balance as of period end
2012-12-31$6.33M-6.9%2014-03-31, Balance as of period end
2011-12-31$6.80M-24.3%2013-03-18, Balance as of period end
2010-12-31$8.98Mn/a2012-03-29, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Nuo Therapeutics, Inc. (AURX)2025-12-31$2.80M+314.7%
OSR Health, Inc. (OSRH)2025-12-31$44.20M+38.0%
Tenon Medical, Inc. (TNON)2025-12-31$5.72M+47.7%
QHSLab, Inc. (USAQ)2025-12-31$546.1K-77.3%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$6.65M+22.4%
Lucid Diagnostics Inc. (LUCD)2025-12-31$29.51M+16.5%
Femasys Inc (FEMY)2025-12-31$14.85M+46.5%
Picard Medical, Inc. (PMI)2025-12-31$18.76M-47.7%
Cerenome, Inc. (CNSY)2025-12-31$12.33M-20.9%

Compare AURX, OSRH, TNON, USAQ side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗